Key result
Genetic analysis in families with arrhythmogenic right ventricular cardiomyopathy is useful for presymptomatic diagnosis and genetic counseling, but does not contribute to risk stratification.
Population
Patients with arrhythmogenic right ventricular dysplasia (ARVD) and their families
Design
Review
Authors
Loading...
Genetic analysis aids ARVC family screening and counseling now; confirms guidelines while leaving risk stratification utility open.
Genetic analysis in ARVD is useful for family screening and counseling but not for risk stratification, aligning with ESC guidelines.
Moric‐Janiszewska et al. (2007) conducted a review in Arrhythmogenic right ventricular dysplasia (ARVD). Genetic analysis was evaluated. Genetic analysis in families with arrhythmogenic right ventricular cardiomyopathy is useful for presymptomatic diagnosis and genetic counseling, but does not contribute to risk stratification.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: